Seachange Intl (SEAC) Shares Declined While Roumell Asset Management Boosted Its Stake; Clear Harbor Asset Management Holding In Gilead Sciences (GILD) Was Upped

November 15, 2017 - By Winifred Garcia

Clear Harbor Asset Management Llc increased its stake in Gilead Sciences Inc (GILD) by 52.85% based on its latest 2017Q2 regulatory filing with the SEC. Clear Harbor Asset Management Llc bought 16,555 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 47,882 shares of the health care company at the end of 2017Q2, valued at $3.34 million, up from 31,327 at the end of the previous reported quarter. Clear Harbor Asset Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $92.92 billion market cap company. The stock declined 0.42% or $0.3 reaching $70.85 on the news. About 38,072 shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 15, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Jim Roumell increased its stake in Seachange Intl Inc (SEAC) by 29.28% based on its latest 2017Q2 regulatory filing with the SEC. Roumell Asset Management Llc bought 213,651 shares as the company’s stock declined 0.40% while stock markets rallied. The hedge fund run by Jim Roumell held 943,335 shares of the technology company at the end of 2017Q2, valued at $2.51M, up from 729,684 at the end of the previous reported quarter. Roumell Asset Management Llc who had been investing in Seachange Intl Inc for a number of months, seems to be bullish on the $91.55M market cap company. It closed at $2.58 lastly. It is down 23.46% since November 15, 2016 and is downtrending. It has underperformed by 40.16% the S&P500.

Investors sentiment decreased to 1.22 in Q2 2017. Its down 0.16, from 1.38 in 2017Q1. It dived, as 8 investors sold SEAC shares while 15 reduced holdings. 12 funds opened positions while 16 raised stakes. 21.24 million shares or 5.25% less from 22.42 million shares in 2017Q1 were reported. Moreover, Axa has 0% invested in SeaChange International (NASDAQ:SEAC). 460,177 are owned by Ameriprise Financial. Parallax Volatility Advisers Lp, a California-based fund reported 20,203 shares. Susquehanna Intll Gru Llp has invested 0% in SeaChange International (NASDAQ:SEAC). Ariel Invs Limited Liability has 0.13% invested in SeaChange International (NASDAQ:SEAC). Savings Bank Of Montreal Can accumulated 174 shares. New York-based Morgan Stanley has invested 0% in SeaChange International (NASDAQ:SEAC). Moreover, National Bank Of New York Mellon has 0% invested in SeaChange International (NASDAQ:SEAC). Prelude Capital Management Limited Liability Company owns 0% invested in SeaChange International (NASDAQ:SEAC) for 7,200 shares. Geode Cap Management Ltd has 184,042 shares for 0% of their portfolio. Renaissance Technologies Limited reported 1.04 million shares or 0% of all its holdings. Connors Investor Services Incorporated reported 669,237 shares. Dsc Advsrs Ltd Partnership has invested 0.22% in SeaChange International (NASDAQ:SEAC). Penn Mgmt Co Incorporated has invested 0.04% in SeaChange International (NASDAQ:SEAC). Price T Rowe Assoc Md holds 29,550 shares.

Among 4 analysts covering SeaChange International (NASDAQ:SEAC), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. SeaChange International had 4 analyst reports since July 24, 2015 according to SRatingsIntel. As per Tuesday, August 23, the company rating was downgraded by Lake Street. Noble Financial downgraded the stock to “Hold” rating in Friday, April 8 report. Dougherty & Company maintained SeaChange International (NASDAQ:SEAC) rating on Wednesday, August 24. Dougherty & Company has “Buy” rating and $6 target. The stock of SeaChange International (NASDAQ:SEAC) has “Hold” rating given on Friday, July 24 by Drexel Hamilton.

More notable recent SeaChange International (NASDAQ:SEAC) news were published by: Seekingalpha.com which released: “Successful Turnaround Continues At SeaChange International On Its Path To A …” on November 09, 2017, also Seekingalpha.com with their article: “SeaChange International: Strong Balance Sheet Provides Floor Until Eventual …” published on May 01, 2017, Globenewswire.com published: “SeaChange Strengthens End User Video Experience at IBC2017” on September 12, 2017. More interesting news about SeaChange International (NASDAQ:SEAC) were released by: Seekingalpha.com and their article: “SeaChange International’s (SEAC) CEO Ed Terino on Q2 2018 Results – Earnings …” published on September 07, 2017 as well as Seekingalpha.com‘s news article titled: “SeaChange International’s (SEAC) Ed Terino on Q1 2018 Results – Earnings Call …” with publication date: June 07, 2017.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 106 analyst reports since July 29, 2015 according to SRatingsIntel. Mizuho maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Thursday, September 28. Mizuho has “Buy” rating and $77.0 target. The rating was maintained by Bank of America on Wednesday, October 4 with “Neutral”. The rating was downgraded by Morgan Stanley on Friday, October 2 to “Equal-Weight”. The rating was maintained by Robert W. Baird on Friday, September 15 with “Buy”. The firm earned “Outperform” rating on Wednesday, November 2 by RBC Capital Markets. RBC Capital Markets maintained it with “Outperform” rating and $95 target in Monday, October 3 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by BMO Capital Markets on Thursday, July 27. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, July 29. Oppenheimer maintained it with “Outperform” rating and $120 target in Wednesday, July 29 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Wednesday, November 8 by Mizuho.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Fool.com which released: “What’s Behind Gilead Sciences Inc.’s $7.8 Billion Slide in October?” on November 02, 2017, also Seekingalpha.com with their article: “Gilead Sciences: More Of The Same, Long Thesis Holds” published on October 31, 2017, Finance.Yahoo.com published: “Gilead Sciences Inc. Still Singing the HCV Blues in the 3rd Quarter” on October 26, 2017. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Marketwatch.com and their article: “Gilead Sciences says its NASH therapy had positive results in mid-stage trial” published on October 24, 2017 as well as Benzinga.com‘s news article titled: “As Gilead’s Outlook Dims, Argus Downgrades” with publication date: November 13, 2017.

Investors sentiment increased to 0.93 in 2017 Q2. Its up 0.02, from 0.91 in 2017Q1. It is positive, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Martin Mngmt Limited holds 144,265 shares or 2.88% of its portfolio. Thematic Ptnrs Llc stated it has 1.05M shares. Penobscot Inv Com Incorporated reported 7,210 shares or 0.16% of all its holdings. Tci Wealth Advsrs accumulated 1,261 shares. Pittenger Anderson stated it has 0% in Gilead Sciences, Inc. (NASDAQ:GILD). Next Financial Group invested 0% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Bailard Incorporated invested in 0.27% or 48,513 shares. Breithorn Mgmt accumulated 66,090 shares. Aviva Public Lc invested 0.37% in Gilead Sciences, Inc. (NASDAQ:GILD). Busey Trust holds 0.69% or 71,056 shares. Profit Mgmt Limited Co reported 9,956 shares. Cullinan Assoc has invested 0.06% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Perkins Coie has invested 0.03% in Gilead Sciences, Inc. (NASDAQ:GILD). Mckinley Cap Mngmt Limited Liability Co Delaware invested in 0.08% or 31,990 shares. Spark Investment Limited Liability Corporation has 0.78% invested in Gilead Sciences, Inc. (NASDAQ:GILD).

Since June 1, 2017, it had 0 buys, and 2 sales for $5.11 million activity. 5,000 Gilead Sciences, Inc. (NASDAQ:GILD) shares with value of $325,114 were sold by Alton Gregg H.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.